Report Detail
Global Rapid-dissolving Tablets Market Growth 2019-2024
- RnM3190489 |
- 26 March, 2019 |
- Global |
- 165 Pages |
- LPI(LP Information) |
- Pharma & Healthcare
Rapid-dissolving Tablets is a drug dosage form available for a limited range of over-the-counter (OTC) and prescription medications. ODTs differ from traditional tablets in that they are designed to be dissolved on the tongue rather than swallowed whole. The ODT serves as an alternative dosage form for patients who experience dysphagia (difficulty in swallowing) or for where compliance is a known issue and therefore an easier dosage form to take ensures that medication is taken.
According to this study, over the next five years the Rapid-dissolving Tablets market will register a xx% CAGR in terms of revenue, the global market size will reach US$ xx million by 2024, from US$ xx million in 2019. In particular, this report presents the global market share (sales and revenue) of key companies in Rapid-dissolving Tablets business, shared in Chapter 3.
This report presents a comprehensive overview, market shares, and growth opportunities of Rapid-dissolving Tablets market by product type, application, key manufacturers and key regions and countries.
This study considers the Rapid-dissolving Tablets value and volume generated from the sales of the following segments:
Segmentation by product type: breakdown data from 2014 to 2019, in Section 2.3; and forecast to 2024 in section 11.7.
Anti-Psychotics Drug
Anti-Epileptics Drug
Other
Segmentation by application: breakdown data from 2014 to 2019, in Section 2.4; and forecast to 2024 in section 11.8.
CNS Diseases
Gastrointestinal Diseases
CVS Diseases
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Spain
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major vendor/manufacturers in the market. The key manufacturers covered in this report: Breakdown data in in Chapter 3.
Teva
Merck
Mylan
Pfizer
Johnson and Johnson
GSK
Otsuka
Eli Lilly and Company
AstraZeneca
Bristol-Myers Squibb
Conquer
In addition, this report discusses the key drivers influencing market growth, opportunities, the challenges and the risks faced by key manufacturers and the market as a whole. It also analyzes key emerging trends and their impact on present and future development.
Research objectives
To study and analyze the global Rapid-dissolving Tablets consumption (value & volume) by key regions/countries, product type and application, history data from 2014 to 2018, and forecast to 2024.
To understand the structure of Rapid-dissolving Tablets market by identifying its various subsegments.
Focuses on the key global Rapid-dissolving Tablets manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Rapid-dissolving Tablets with respect to individual growth trends, future prospects, and their contribution to the total market.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
To project the consumption of Rapid-dissolving Tablets submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.
Table of Contents
2019-2024 Global Rapid-dissolving Tablets Consumption Market Report
1 Scope of the Report
- 1.1 Market Introduction
- 1.2 Research Objectives
- 1.3 Years Considered
- 1.4 Market Research Methodology
- 1.5 Economic Indicators
- 1.6 Currency Considered
2 Executive Summary
- 2.1 World Market Overview
- 2.1.1 Global Rapid-dissolving Tablets Consumption 2014-2024
- 2.1.2 Rapid-dissolving Tablets Consumption CAGR by Region
- 2.2 Rapid-dissolving Tablets Segment by Type
- 2.2.1 Anti-Psychotics Drug
- 2.2.2 Anti-Epileptics Drug
- 2.2.3 Other
- 2.3 Rapid-dissolving Tablets Consumption by Type
- 2.3.1 Global Rapid-dissolving Tablets Consumption Market Share by Type (2014-2019)
- 2.3.2 Global Rapid-dissolving Tablets Revenue and Market Share by Type (2014-2019)
- 2.3.3 Global Rapid-dissolving Tablets Sale Price by Type (2014-2019)
- 2.4 Rapid-dissolving Tablets Segment by Application
- 2.4.1 CNS Diseases
- 2.4.2 Gastrointestinal Diseases
- 2.4.3 CVS Diseases
- 2.4.4 Other
- 2.5 Rapid-dissolving Tablets Consumption by Application
- 2.5.1 Global Rapid-dissolving Tablets Consumption Market Share by Application (2014-2019)
- 2.5.2 Global Rapid-dissolving Tablets Value and Market Share by Application (2014-2019)
- 2.5.3 Global Rapid-dissolving Tablets Sale Price by Application (2014-2019)
3 Global Rapid-dissolving Tablets by Players
- 3.1 Global Rapid-dissolving Tablets Sales Market Share by Players
- 3.1.1 Global Rapid-dissolving Tablets Sales by Players (2017-2019)
- 3.1.2 Global Rapid-dissolving Tablets Sales Market Share by Players (2017-2019)
- 3.2 Global Rapid-dissolving Tablets Revenue Market Share by Players
- 3.2.1 Global Rapid-dissolving Tablets Revenue by Players (2017-2019)
- 3.2.2 Global Rapid-dissolving Tablets Revenue Market Share by Players (2017-2019)
- 3.3 Global Rapid-dissolving Tablets Sale Price by Players
- 3.4 Global Rapid-dissolving Tablets Manufacturing Base Distribution, Sales Area, Product Types by Players
- 3.4.1 Global Rapid-dissolving Tablets Manufacturing Base Distribution and Sales Area by Players
- 3.4.2 Players Rapid-dissolving Tablets Products Offered
- 3.5 Market Concentration Rate Analysis
- 3.5.1 Competition Landscape Analysis
- 3.5.2 Concentration Ratio (CR3, CR5 and CR10) (2017-2019)
- 3.6 New Products and Potential Entrants
- 3.7 Mergers & Acquisitions, Expansion
4 Rapid-dissolving Tablets by Regions
- 4.1 Rapid-dissolving Tablets by Regions
- 4.1.1 Global Rapid-dissolving Tablets Consumption by Regions
- 4.1.2 Global Rapid-dissolving Tablets Value by Regions
- 4.2 Americas Rapid-dissolving Tablets Consumption Growth
- 4.3 APAC Rapid-dissolving Tablets Consumption Growth
- 4.4 Europe Rapid-dissolving Tablets Consumption Growth
- 4.5 Middle East & Africa Rapid-dissolving Tablets Consumption Growth
5 Americas
- 5.1 Americas Rapid-dissolving Tablets Consumption by Countries
- 5.1.1 Americas Rapid-dissolving Tablets Consumption by Countries (2014-2019)
- 5.1.2 Americas Rapid-dissolving Tablets Value by Countries (2014-2019)
- 5.2 Americas Rapid-dissolving Tablets Consumption by Type
- 5.3 Americas Rapid-dissolving Tablets Consumption by Application
- 5.4 United States
- 5.5 Canada
- 5.6 Mexico
- 5.7 Key Economic Indicators of Few Americas Countries
6 APAC
- 6.1 APAC Rapid-dissolving Tablets Consumption by Countries
- 6.1.1 APAC Rapid-dissolving Tablets Consumption by Countries (2014-2019)
- 6.1.2 APAC Rapid-dissolving Tablets Value by Countries (2014-2019)
- 6.2 APAC Rapid-dissolving Tablets Consumption by Type
- 6.3 APAC Rapid-dissolving Tablets Consumption by Application
- 6.4 China
- 6.5 Japan
- 6.6 Korea
- 6.7 Southeast Asia
- 6.8 India
- 6.9 Australia
- 6.10 Key Economic Indicators of Few APAC Countries
7 Europe
- 7.1 Europe Rapid-dissolving Tablets by Countries
- 7.1.1 Europe Rapid-dissolving Tablets Consumption by Countries (2014-2019)
- 7.1.2 Europe Rapid-dissolving Tablets Value by Countries (2014-2019)
- 7.2 Europe Rapid-dissolving Tablets Consumption by Type
- 7.3 Europe Rapid-dissolving Tablets Consumption by Application
- 7.4 Germany
- 7.5 France
- 7.6 UK
- 7.7 Italy
- 7.8 Russia
- 7.9 Spain
- 7.10 Key Economic Indicators of Few Europe Countries
8 Middle East & Africa
- 8.1 Middle East & Africa Rapid-dissolving Tablets by Countries
- 8.1.1 Middle East & Africa Rapid-dissolving Tablets Consumption by Countries (2014-2019)
- 8.1.2 Middle East & Africa Rapid-dissolving Tablets Value by Countries (2014-2019)
- 8.2 Middle East & Africa Rapid-dissolving Tablets Consumption by Type
- 8.3 Middle East & Africa Rapid-dissolving Tablets Consumption by Application
- 8.4 Egypt
- 8.5 South Africa
- 8.6 Israel
- 8.7 Turkey
- 8.8 GCC Countries
9 Market Drivers, Challenges and Trends
- 9.1 Market Drivers and Impact
- 9.1.1 Growing Demand from Key Regions
- 9.1.2 Growing Demand from Key Applications and Potential Industries
- 9.2 Market Challenges and Impact
- 9.3 Market Trends
10 Marketing, Distributors and Customer
- 10.1 Sales Channel
- 10.1.1 Direct Channels
- 10.1.2 Indirect Channels
- 10.2 Rapid-dissolving Tablets Distributors
- 10.3 Rapid-dissolving Tablets Customer
11 Global Rapid-dissolving Tablets Market Forecast
- 11.1 Global Rapid-dissolving Tablets Consumption Forecast (2019-2024)
- 11.2 Global Rapid-dissolving Tablets Forecast by Regions
- 11.2.1 Global Rapid-dissolving Tablets Forecast by Regions (2019-2024)
- 11.2.2 Global Rapid-dissolving Tablets Value Forecast by Regions (2019-2024)
- 11.2.3 Americas Consumption Forecast
- 11.2.4 APAC Consumption Forecast
- 11.2.5 Europe Consumption Forecast
- 11.2.6 Middle East & Africa Consumption Forecast
- 11.3 Americas Forecast by Countries
- 11.3.1 United States Market Forecast
- 11.3.2 Canada Market Forecast
- 11.3.3 Mexico Market Forecast
- 11.3.4 Brazil Market Forecast
- 11.4 APAC Forecast by Countries
- 11.4.1 China Market Forecast
- 11.4.2 Japan Market Forecast
- 11.4.3 Korea Market Forecast
- 11.4.4 Southeast Asia Market Forecast
- 11.4.5 India Market Forecast
- 11.4.6 Australia Market Forecast
- 11.5 Europe Forecast by Countries
- 11.5.1 Germany Market Forecast
- 11.5.2 France Market Forecast
- 11.5.3 UK Market Forecast
- 11.5.4 Italy Market Forecast
- 11.5.5 Russia Market Forecast
- 11.5.6 Spain Market Forecast
- 11.6 Middle East & Africa Forecast by Countries
- 11.6.1 Egypt Market Forecast
- 11.6.2 South Africa Market Forecast
- 11.6.3 Israel Market Forecast
- 11.6.4 Turkey Market Forecast
- 11.6.5 GCC Countries Market Forecast
- 11.7 Global Rapid-dissolving Tablets Forecast by Type
- 11.8 Global Rapid-dissolving Tablets Forecast by Application
12 Key Players Analysis
- 12.1 Teva
- 12.1.1 Company Details
- 12.1.2 Rapid-dissolving Tablets Product Offered
- 12.1.3 Teva Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.1.4 Main Business Overview
- 12.1.5 Teva News
- 12.2 Merck
- 12.2.1 Company Details
- 12.2.2 Rapid-dissolving Tablets Product Offered
- 12.2.3 Merck Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.2.4 Main Business Overview
- 12.2.5 Merck News
- 12.3 Mylan
- 12.3.1 Company Details
- 12.3.2 Rapid-dissolving Tablets Product Offered
- 12.3.3 Mylan Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.3.4 Main Business Overview
- 12.3.5 Mylan News
- 12.4 Pfizer
- 12.4.1 Company Details
- 12.4.2 Rapid-dissolving Tablets Product Offered
- 12.4.3 Pfizer Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.4.4 Main Business Overview
- 12.4.5 Pfizer News
- 12.5 Johnson and Johnson
- 12.5.1 Company Details
- 12.5.2 Rapid-dissolving Tablets Product Offered
- 12.5.3 Johnson and Johnson Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.5.4 Main Business Overview
- 12.5.5 Johnson and Johnson News
- 12.6 GSK
- 12.6.1 Company Details
- 12.6.2 Rapid-dissolving Tablets Product Offered
- 12.6.3 GSK Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.6.4 Main Business Overview
- 12.6.5 GSK News
- 12.7 Otsuka
- 12.7.1 Company Details
- 12.7.2 Rapid-dissolving Tablets Product Offered
- 12.7.3 Otsuka Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.7.4 Main Business Overview
- 12.7.5 Otsuka News
- 12.8 Eli Lilly and Company
- 12.8.1 Company Details
- 12.8.2 Rapid-dissolving Tablets Product Offered
- 12.8.3 Eli Lilly and Company Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.8.4 Main Business Overview
- 12.8.5 Eli Lilly and Company News
- 12.9 AstraZeneca
- 12.9.1 Company Details
- 12.9.2 Rapid-dissolving Tablets Product Offered
- 12.9.3 AstraZeneca Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.9.4 Main Business Overview
- 12.9.5 AstraZeneca News
- 12.10 Bristol-Myers Squibb
- 12.10.1 Company Details
- 12.10.2 Rapid-dissolving Tablets Product Offered
- 12.10.3 Bristol-Myers Squibb Rapid-dissolving Tablets Sales, Revenue, Price and Gross Margin (2017-2019)
- 12.10.4 Main Business Overview
- 12.10.5 Bristol-Myers Squibb News
- 12.11 Conquer
13 Research Findings and Conclusion
Summary:
Get latest Market Research Reports on Rapid-dissolving Tablets . Industry analysis & Market Report on Rapid-dissolving Tablets is a syndicated market report, published as Global Rapid-dissolving Tablets Market Growth 2019-2024. It is complete Research Study and Industry Analysis of Rapid-dissolving Tablets market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
